SecBot SecBot
SECBOTREPLAY Home › Report › TWST

TWST · Twist Bioscience CEO Emily Leproust sold $14.2M of stock via a…

Twist Bioscience Corp · CLUSTER filed Aug 14, 2026 at 16:12 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Aug 14, 2026 at 16:12 ET

Twist Bioscience CEO Emily Leproust sold $14.2M of stock via a derivative exercise-and-sell transaction, while two directors and another executive also sold shares totaling ~$18.1M in the week following a strong Q3 earnings beat. The cluster is dominated by the CEO's open-market sale, which is the largest insider sell at the company in the past 30 days ($18.7M total prior). The sales follow an earnings report that beat consensus and raised guidance, but the CEO's sale is a large, non-10b5-1 disposition that may signal limited upside at current levels near $125.

  • CEO Emily Leproust sold 113,318 shares on 2026-08-10 at ~$125.16, netting $14.18M in open-market proceeds after exercising options at $26.66.
  • Director Katryn Blake sold 2,240 shares at $122.88 for $275K on 2026-08-12.
  • Director Robert Chess sold 18,400 shares at $110.89 for $2.04M on 2026-08-07.
  • Executive Dennis Cho sold 14,200 shares at $109.75 for $1.56M on 2026-08-05.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access